GB0008660D0
(en)
*
|
2000-04-07 |
2000-05-31 |
Arakis Ltd |
The treatment of respiratory diseases
|
DE10136404A1
(en)
*
|
2001-07-26 |
2003-02-20 |
Johannes Wohlrab |
Topical medicament for treating or preventing hyperhidrosis, e.g. hyperhidrosis axillaris, comprises glycopyrrolate compound in gel and/or colloid-containing vehicle system
|
IL152486A0
(en)
|
2002-10-25 |
2003-05-29 |
Meir Eini |
Alcohol-free cosmetic and pharmaceutical foam carrier
|
US7820145B2
(en)
|
2003-08-04 |
2010-10-26 |
Foamix Ltd. |
Oleaginous pharmaceutical and cosmetic foam
|
US8900554B2
(en)
|
2002-10-25 |
2014-12-02 |
Foamix Pharmaceuticals Ltd. |
Foamable composition and uses thereof
|
US7700076B2
(en)
|
2002-10-25 |
2010-04-20 |
Foamix, Ltd. |
Penetrating pharmaceutical foam
|
US10117812B2
(en)
|
2002-10-25 |
2018-11-06 |
Foamix Pharmaceuticals Ltd. |
Foamable composition combining a polar solvent and a hydrophobic carrier
|
US9211259B2
(en)
|
2002-11-29 |
2015-12-15 |
Foamix Pharmaceuticals Ltd. |
Antibiotic kit and composition and uses thereof
|
US20080138296A1
(en)
|
2002-10-25 |
2008-06-12 |
Foamix Ltd. |
Foam prepared from nanoemulsions and uses
|
US9668972B2
(en)
|
2002-10-25 |
2017-06-06 |
Foamix Pharmaceuticals Ltd. |
Nonsteroidal immunomodulating kit and composition and uses thereof
|
US9265725B2
(en)
|
2002-10-25 |
2016-02-23 |
Foamix Pharmaceuticals Ltd. |
Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
|
US7704518B2
(en)
|
2003-08-04 |
2010-04-27 |
Foamix, Ltd. |
Foamable vehicle and pharmaceutical compositions thereof
|
ES2532906T5
(en)
|
2002-10-25 |
2022-03-23 |
Foamix Pharmaceuticals Ltd |
Cosmetic and pharmaceutical foam
|
US8795693B2
(en)
|
2003-08-04 |
2014-08-05 |
Foamix Ltd. |
Compositions with modulating agents
|
US7091236B1
(en)
|
2003-08-20 |
2006-08-15 |
Sciele Pharma, Inc. |
Method for increasing the bioavailability of glycopyrrolate
|
DE102005029390A1
(en)
*
|
2005-06-23 |
2007-01-04 |
Beiersdorf Ag |
Combination, useful as cosmetic deodorant and antitranspirants, comprises glycopyrronium bromide and active materials e.g. boundary surface-active substances, polyols and hydrocolloids
|
US8343467B2
(en)
|
2004-12-27 |
2013-01-01 |
Beiersdorf Ag |
Glycopyrrolate in cosmetic preparations
|
DE102005029386A1
(en)
*
|
2005-06-23 |
2007-01-11 |
Beiersdorf Ag |
Combination, useful as cosmetic deodorant and antitranspirants, comprises glycopyrronium bromide and active materials e.g. boundary surface-active substances, polyols and hydrocolloids
|
WO2006078998A2
(en)
*
|
2005-01-19 |
2006-07-27 |
Neurohealing Pharmaceuticals, Inc. |
Methods and compositions for decreasing saliva production
|
PT1986642E
(en)
*
|
2006-02-13 |
2014-01-30 |
Orient Pharma Samoa Co Ltd |
Combination of alpha-2 receptor agonist (clonidine) and an anti-muscarinic agent (oxybutynin) for the treatment of sialorrhoea
|
GB0602857D0
(en)
*
|
2006-02-13 |
2006-03-22 |
Daniolabs Ltd |
The treatment of sialorrhoea
|
US20080260655A1
(en)
|
2006-11-14 |
2008-10-23 |
Dov Tamarkin |
Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
|
US20080260823A1
(en)
*
|
2007-04-20 |
2008-10-23 |
Sciele Pharma, Inc. |
Orally disintegrating tablet comprising glycopyrrolate for treating sialorrhea
|
JP2010530902A
(en)
*
|
2007-06-22 |
2010-09-16 |
サイエル ファーマ,インコーポレイティド |
Transdermal delivery system containing glycopyrrolate for the treatment of fluency
|
US8636982B2
(en)
|
2007-08-07 |
2014-01-28 |
Foamix Ltd. |
Wax foamable vehicle and pharmaceutical compositions thereof
|
GB0715790D0
(en)
*
|
2007-08-13 |
2007-09-26 |
Summit Corp Plc |
Drug combination for the treatment of sialorrhoea
|
WO2009069006A2
(en)
|
2007-11-30 |
2009-06-04 |
Foamix Ltd. |
Foam containing benzoyl peroxide
|
WO2009072007A2
(en)
|
2007-12-07 |
2009-06-11 |
Foamix Ltd. |
Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
|
US20100055045A1
(en)
|
2008-02-26 |
2010-03-04 |
William Gerhart |
Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations
|
CA2760186C
(en)
|
2009-04-28 |
2019-10-29 |
Foamix Ltd. |
Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
|
CA2769625C
(en)
|
2009-07-29 |
2017-04-11 |
Foamix Ltd. |
Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
|
CA2769677A1
(en)
|
2009-07-29 |
2011-02-03 |
Foamix Ltd. |
Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
|
US9849142B2
(en)
|
2009-10-02 |
2017-12-26 |
Foamix Pharmaceuticals Ltd. |
Methods for accelerated return of skin integrity and for the treatment of impetigo
|
MX359879B
(en)
|
2009-10-02 |
2018-10-12 |
Foamix Pharmaceuticals Ltd |
Topical tetracycline compositions.
|
US9006462B2
(en)
|
2013-02-28 |
2015-04-14 |
Dermira, Inc. |
Glycopyrrolate salts
|
KR102377252B1
(en)
|
2013-02-28 |
2022-03-22 |
저니 메디컬 코퍼레이션 |
Glycopyrrolate salts
|
US8558008B2
(en)
|
2013-02-28 |
2013-10-15 |
Dermira, Inc. |
Crystalline glycopyrrolate tosylate
|
JP7270958B2
(en)
|
2015-09-11 |
2023-05-11 |
ボドール ラボラトリーズ, インコーポレイテッド |
Methods and compositions for low toxicity anticholinergic esters
|
CA2998353A1
(en)
*
|
2015-09-11 |
2017-03-16 |
Bodor Laboratories, Inc. |
Methods and compositions for soft anticholinergic zwitterions
|
EP4230202A1
(en)
*
|
2016-02-12 |
2023-08-23 |
The United States Government Represented by the Department of Veterans Affairs |
Bowel care using iontophoresis
|
MX2017011630A
(en)
|
2016-09-08 |
2018-09-25 |
Foamix Pharmaceuticals Ltd |
Compositions and methods for treating rosacea and acne.
|
US11110054B2
(en)
|
2018-05-09 |
2021-09-07 |
Slayback Pharma Llc |
Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolate
|